October 23, 2009 – Today, Genentech and FDA notified healthcare professionals about a third case of progressive multifocal leukoencephalopathy [PML], the first case of PML in a patient with rheumatoid arthritis [RA] treated with Rituximab [Rituxan] who has not previously …

Rituximab [Rituxan] – Progressive Multifocal Leukoencephalopathy [PML] Read more »